Human studies have indicated that variants in genes encoding ENaC chains can cause functional abnormalities, which result in CF-like symptoms, and that rare mutations causing reduced ENaC activity can slow disease progression in patients homozygous for CFTR ΔF508 mutation [73, 74]. The gene discussed is CFTR; the disease is cystic fibrosis.